What the microbiome does

The gut microbiome performs functions that the human genome cannot perform alone, functions so central to health that they were once attributed to human biology rather than microbial symbionts. These include: synthesising vitamins K2, B12, B7 (biotin), and folate; producing short-chain fatty acids (SCFAs), butyrate, propionate, and acetate, that feed gut lining cells, reduce systemic inflammation, and regulate immune function; converting inactive dietary compounds into bioactive forms; metabolising bile acids in ways that regulate fat digestion, cholesterol homeostasis, and glucose metabolism; directly training and modulating the gut-associated immune system (GALT); and producing neurotransmitter precursors including 95% of the body's serotonin and significant quantities of GABA and dopamine precursors.

The microbiome is not fixed at birth. It is continuously shaped by diet, medication use, stress, sleep quality, physical activity, and environmental exposures, throughout life. This means it is readily disrupted by modern lifestyle patterns, and readily responsive to restoration.

"The microbiome is not a separate entity living in the gut. It is a functional extension of human biology, one that modern medicine has spent decades inadvertently destroying."

Key bacterial species and their roles

🟒
Faecalibacterium prausnitzii
One of the most important gut bacteria for human health, producing butyrate that fuels colonocytes, reducing intestinal inflammation, and directly modulating Th17/Treg immune balance. Its deficiency is commonly found in IBD, psoriasis, rheumatoid arthritis, and metabolic disease. It is extremely sensitive to antibiotics and low-fibre diets.
🟒
Akkermansia muciniphila
A mucus-layer-resident bacterium that maintains gut barrier integrity and is inversely associated with obesity, metabolic syndrome, and type 2 diabetes. Elevated Akkermansia is associated with improved insulin sensitivity and reduced gut permeability. Polyphenol-rich foods and intermittent fasting promote its growth.
🟒
Lactobacillus and Bifidobacterium species
The most studied probiotic genera, producing lactic acid that maintains gut pH, competing with pathogenic species, producing GABA (Lactobacillus rhamnosus), and supporting gut barrier function. Bifidobacterium species are particularly reduced by antibiotic use and ageing.
πŸ”΄
Prevotella copri
Elevated in some rheumatoid arthritis patients before clinical disease onset, directly implicated in Th17-driven joint inflammation. Its presence in RA patients correlates with anti-citrullinated protein antibody positivity.
πŸ”΄
Clostridioides difficile
Overgrows in antibiotic-disrupted microbiomes, producing toxins that cause severe intestinal inflammation. Its proliferation exemplifies how antibiotic-induced microbiome disruption creates ecological niches for opportunistic pathogens.

Dysbiosis, when the microbiome goes wrong

Dysbiosis describes the state of microbial imbalance, reduced diversity, overgrowth of potentially harmful species, or loss of key beneficial species, that produces the downstream consequences seen across chronic disease. Dysbiosis is not a diagnosis; it is a spectrum. Its consequences depend on which species are lost, which overgrow, and which functional pathways are disrupted as a result.

Key Concept
Diversity is protective
The microbiome's protective capacity is proportional to its diversity. A microbiome with 300 functionally diverse species is resilient, if one species is lost, others can compensate. A microbiome that has been reduced to 50 species through repeated antibiotic use, low-fibre diet, and chronic stress is fragile, each additional insult produces disproportionate functional loss. Diversity is the single most important microbiome health indicator, and it is reduced by virtually every feature of modern lifestyle.

The microbiome's role across chronic conditions

The following conditions all have documented microbiome alterations as primary or significant contributing factors, most directly IBS, where gut bacterial composition is one of the best-established drivers of symptom severity and pattern. In each case, the microbiome alterations are not simply correlations, they participate directly in the disease mechanism through the pathways described above.

How microbiome restoration works in clinical practice

Microbiome restoration is not simply the consumption of probiotic supplements, though targeted probiotic support has an appropriate role. It is a structured approach to changing the ecological environment of the gut to favour beneficial species and discourage pathogenic overgrowth.

Prebiotic fibre is the most important dietary intervention, fermentable fibres (inulin, FOS, resistant starch, pectin) feed the Faecalibacterium, Akkermansia, and Bifidobacterium species that underpin gut health. A diet with fewer than 20g of fibre per day tends to produce microbiome impoverishment; 30–40g per day, from diverse plant sources, is the minimum for meaningful microbiome support.

Dietary diversity drives microbiome diversity, the number of different plant species consumed per week is a stronger predictor of microbiome diversity than any individual food. Consuming 30 or more different plant foods per week, including herbs, spices, nuts, seeds, and legumes, produces measurably greater microbiome diversity than diets with fewer species even at equal fibre intake.

Polyphenols, the plant compounds in colourful fruits, vegetables, olive oil, dark chocolate, and green tea, selectively feed beneficial microbiome species and produce direct anti-inflammatory and barrier-protective effects in the gut independently of their fibre content.

Targeted probiotic support, specific strains with clinical evidence for the specific condition being addressed, provides direct supplementation of depleted species where dietary restoration alone is insufficient or too slow. The specific strain matters: Lactobacillus rhamnosus GG for gut barrier repair differs meaningfully from Lactobacillus acidophilus for lactose intolerance.